Search

Purpose: High dose rate (HDR) brachytherapy rapidly delivers dose to targets with steep dose gradients. This treatment method must adhere to prescribed treatment plans with high spatiotemporal accuracy and precision, as failure to do so may degrade clinical outcomes. One approach to achieving this goal is to develop imaging techniques to track HDR sources in vivo in reference to surrounding anatomy. This work investigates the feasibility of using an isocentric C‐arm x‐ray imager and tomosynthesis methods to track Ir‐192 HDR brachytherapy sources in vivo over time (4D). Methods: A tomosynthesis imaging workflow was proposed and its achievable source detectability, localization accuracy, and spatiotemporal resolution were investigated in silico. An anthropomorphic female XCAT phantom was modified to include a vaginal cylinder applicator and Ir‐192 HDR source (0.5 × 0.5 × 5.0 mm3), and the workflow was carried out using the MC‐GPU Monte Carlo image simulation platform. Source detectability was characterized using the reconstructed source signal‐difference‐to‐noise‐ratio (SDNR), localization accuracy by the absolute 3D error in its measured centroid location, and spatiotemporal resolution by the full‐width‐at‐half‐maximum (FWHM) of line profiles through the source in each spatial dimension considering a maximum C‐arm angular velocity of 30° per second. The dependence of these parameters on acquisition angular range (θtot = 0°–90°), number of views, angular increment between views (Δθ = 0°–15°), and volumetric constraints imposed in reconstruction was evaluated. Organ voxel doses were tallied to derive the workflow's attributable effective dose. Results: The HDR source was readily detected and its centroid was accurately localized with the proposed workflow and method (SDNR: 10–40, 3D error: 0–0.144 mm). Tradeoffs were demonstrated for various combinations of image acquisition parameters; namely, increasing the tomosynthesis acquisition angular range improved resolution in the depth‐encoded direction, for example from 2.5 mm to 1.2 mm between θtot = 30o and θtot = 90o, at the cost of increasing acquisition time from 1 to 3 s. The best‐performing acquisition parameters (θtot = 90o, Δθ = 1°) yielded no centroid localization error, and achieved submillimeter source resolution (0.57 × 1.21 × 5.04 mm3 apparent source dimensions, FWHM). The total effective dose for the workflow was 263 µSv for its required pre‐treatment imaging component and 7.59 µSv per mid‐treatment acquisition thereafter, which is comparable to common diagnostic radiology exams. Conclusions: A system and method for tracking HDR brachytherapy sources in vivo using C‐arm tomosynthesis was proposed and its performance investigated in silico. Tradeoffs in source conspicuity, localization accuracy, spatiotemporal resolution, and dose were determined. The results suggest this approach is feasible for localizing an Ir‐192 HDR source in vivo with submillimeter spatial resolution, 1–3 second temporal resolution and minimal additional dose burden. [ABSTRACT FROM AUTHOR]